The 5 Stocks That Sank Markets on Friday
thinkstockMarch 21, 2014: Markets opened higher on Friday but the Nasdaq sank quickly, bounced for a while, and finally settled solidly lower. It took the Dow and the S&P 500 until noon to really…
Archive
Year: 2014
All Year: 2014 Articles
Newest first · Page 386Visa, MasterCard Cut Service to Two Russian Banks
ThinkstockFollowing President Obama’s order on Thursday of sanctions against two dozen Russian citizens, credit card issuers Visa Inc. (NYSE: V) and MasterCard Inc. (NYSE: MA) have stopped providing services to two Russian Banks. One…
Zogenix CEO Goes on the Offensive
Zogenix has traded like a company that is about to implode. Its highly controversial Zohydro has been getting inquiries into how it was approved for marketing despite an FDA panel being against the recommendation.
Biopharma Firm Versartis Gets Golden IPO Treatment
Biopharmaceutical firm Versartis sold 6 million shares in a Friday morning IPO at a price higher than the estimated range. Shares were up more than 60% in the noon hour.
Borderfree IPO Follows Lead of Other Recent Techs: Higher
Borderfree offered 5 million shares in an initial public offering Friday morning. Shares priced at the top of their expected range. Shares were up more than 20% in morning trading.
Companies That Love March Madness the Most
ThinkstockMarch Madness has arrived for you college basketball fans. What is different about March Madness, versus the Daytona 500, the Indy 500, the Super Bowl, and other key sporting events, is that March Madness…
Amber Road IPO Races Off the Line
Amber Road, a maker of cloud-based software for global trade management, held its initial public offering (IPO) Friday, selling 7.4 million shares at a price of $13 a piece. Shares were up 30% in…
Ten American Cities With the Highest Unemployment
squirrel83, via Wikimedia CommonsThe Bureau of Labor Statistics has released its data on unemployment by city for January. In general, the news was very good. Jobless rates were lower in 367 of the 372…
Did Endocyte Just Become Buyout Bait?
Endocyte is trading like it is being acquired. This is proof that any biotech with great cancer drug news can run, regardless of market conditions. One has to wonder if Endocyte is among the…
Nike: A Time to Buy?
Since being added to the Dow Jones Industrials Index last September, shares of Nike are up just over 11%. In the same period, Under Armour is up 57%. But that is not an entirely…
Baird Very Cautious on Energy: Six Top Stocks to Buy Now
The Baird plan of action is pretty easy for investors to follow. Keep a smaller allocation of the energy sector, as they rate it Neutral, and only buy the top stocks that have the…
Merrill Lynch Defends Home Depot, Says It Is Headed to $100
Bank of America Merrill Lynch is defending Home Depot. What stands out here is not just that the firm is reiterating its Buy rating, but that it is calling for Home Depot shares to…
Could Obamacare Be Working?
WellPoint raised its earnings outlook for the 2014 fiscal year, citing a benefit from the Affordable Care Act, aka Obamacare, and the expected addition of a million or more new members.
Herbalife Takes Key Independent Research Analyst Downgrade
Argus has downgraded Herbalife's near-term rating to Hold from Buy. The basis for the call is the recently announced Federal Trade Commission investigation into Herbalife's business practices, including its operations in China.
Credit Suisse’s Top Stocks to Buy for a Difficult 2014
After a huge run, it may be time to avoid momentum stocks and focus on quality names that will not get shellacked should the market have a substantial correction. Here are Credit Suisse's picks…